Document Detail


Prognostic indicators in venous ulcers.
MedLine Citation:
PMID:  11004617     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Venous ulcers can be difficult to heal, and prognostic factors for healing have not been fully elucidated. OBJECTIVE: The objective of this study was to analyze the results of a large multicenter venous ulcer trial to retrospectively establish prognostic factors for venous ulcer healing. METHODS: This study examined data from a previously published prospective randomized placebo-controlled trial of an oral medication versus placebo treatment for venous ulcers. Local leg ulcer care involved the use of a moisture-retentive dressing and sustained graduated compression with a paste bandage and a self-adherent wrap. The oral medication or placebo was administered on a daily basis with the same dressings and bandage system in both groups for 12 weeks. A total of 165 patients completed the full 12-week treatment period; 83 received ifetroban, 82 received placebo. RESULTS: There was no statistically significant difference in outcome between the two groups. The study showed that consistent local ulcer treatment with a clearly defined system of care was associated with an unexpectedly high percentage (55%) of long-standing large venous ulcers (mean duration, 27 months; mean area, 15.9 cm(2)) being healed in both groups. Baseline ulcer area and duration of leg ulcer were found to be important in predicting outcome. Ulcers of short duration were found to be most likely to heal. Percent healing and ulcer area at week 3 were good predictors of 100% healing. Ulcers that had at least 40% healing by week 3 predicted more than 70% of the outcomes correctly. CONCLUSION: From this large study it was determined that baseline ulcer area and ulcer duration are significant predictors of 100% healing and time to heal. Percent healing and ulcer area at week 3 are good predictors of complete ulcer healing. Ulcers that are large, long-standing, and slow to heal after 3 weeks of optimal therapy are unlikely to heal rapidly, and might benefit from alternative therapies.
Authors:
T J Phillips; F Machado; R Trout; J Porter; J Olin; V Falanga
Related Documents :
19610037 - Evaluation of healing and antimicrobiological effects of herbal therapy on venous leg u...
1982317 - Impact of h2-receptor antagonists on the outcome of treatment of perforated duodenal ul...
3533007 - Pressure ulcer management in home health care: efficacy and cost effectiveness of moist...
7901267 - Nsaid-induced gastroduodenal damage: is prevention needed? a review and metaanalysis.
1854027 - Comparison of continuous epidural bupivacaine infusion plus either continuous epidural ...
11564027 - The barbagli procedure gives the best results for patch urethroplasty of the bulbar ure...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  43     ISSN:  0190-9622     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-11-20     Completed Date:  2000-11-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  627-30     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Double-Blind Method
Humans
Prognosis
Prospective Studies
Randomized Controlled Trials as Topic
Remission Induction
Retrospective Studies
Varicose Ulcer / therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of pa...
Next Document:  Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an enti...